dydrogesterone has been researched along with Flushing in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dain, MP; MacCarthy, K; Studd, JW; Zamblera, D | 1 |
1 trial(s) available for dydrogesterone and Flushing
Article | Year |
---|---|
Efficacy and safety of Menorest (50 mikrog/day) compared to Premarin 0.625 mg in the treatment of menopausal symptoms and the prevention of bone loss, in menopausal women. A single-center, comparative, randomized, double-blind, double-dummy study.
Topics: Bone Density; Double-Blind Method; Dydrogesterone; Estradiol; Estrogens, Conjugated (USP); Female; Flushing; Humans; Menopause; Osteoporosis, Postmenopausal; Pilot Projects | 1996 |